GE HealthCare Technologies Inc.
GEHC · Healthcare · Health Care
Updated 25 min ago · data delayed ≥15 min
IconicScore
ProprietaryRanked #304 of 500 by Iconic Score · #40 of 59in its sector. IconicAlpha’s proprietary brand-intelligence metric — a multi-model blend of scale, market attention, category leadership, and AI-analyzed brand visibility.
Get the free morning email
The biggest IconicScore™ gainer and loser, plus the strongest and weakest sectors, in your inbox before the open. See a sample →
Price performance
Export history · AnalystThis insight is part of the Analyst tier — unlock the IconicScore vs. price overlay, side-by-side comparison, and CSV export.
Upgrade to AnalystThis is part of the Enterprise tier — benchmark your IconicScore against sector peers, claim your profile, and manage how your brand appears on the wall.
Upgrade to EnterpriseIconic Profile
GE Healthcare Technologies Inc (GEHC) is a leading global provider of medical imaging, monitoring, and diagnostic technologies, operating within the healthcare sector. With a market capitalization of $28.2 billion, the company specializes in advanced medical devices and software solutions that enhance patient care and streamline clinical workflows. GEHC's diverse product portfolio includes MRI, CT, ultrasound, and molecular imaging systems, as well as data analytics and artificial intelligence applications that support healthcare providers in delivering efficient and effective patient outcomes. Positioned as a key player in the healthcare technology market, GEHC is critical for advancing medical innovation and improving healthcare delivery, making it a significant contributor to the ongoing transformation of the healthcare landscape. Its commitment to research and development ensures that it remains at the forefront of technological advancements, addressing the evolving needs of healthcare professionals and patients worldwide.
IconicOracleAI™ Brief
GE Healthcare Technologies Inc (GEHC) currently holds an Iconic Score of 41, reflecting a moderate brand presence amid recent developments. The company has garnered attention through strategic collaborations and product approvals, such as the MINItrace Magni Cyclotron in Europe and the expansion of its ultrasound portfolio. Despite these advancements, the stock has experienced a decline of 1.74%, indicating mixed sentiment in the market. The brand's visibility remains strong with a score of 85/100, highlighting its recognition in the healthcare technology sector.
AI-generated explanation of current score drivers. Not investment advice.
Enterprise tier: claim your logo to manage how your brand is represented.